- Home
- DAC vs NVAX Comparison
DAC vs NVAX Comparison
Compare DAC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAC
- NVAX
- Stock Information
- Founded
- DAC 1972
- NVAX 1987
- Country
- DAC Greece
- NVAX United States
- Employees
- DAC N/A
- NVAX N/A
- Industry
- DAC Marine Transportation
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DAC Consumer Discretionary
- NVAX Health Care
- Exchange
- DAC Nasdaq
- NVAX Nasdaq
- Market Cap
- DAC 1.6B
- NVAX 1.3B
- IPO Year
- DAC 2006
- NVAX 1995
- Fundamental
- Price
- DAC $89.85
- NVAX $7.00
- Analyst Decision
- DAC Strong Buy
- NVAX Buy
- Analyst Count
- DAC 1
- NVAX 5
- Target Price
- DAC $105.00
- NVAX $16.60
- AVG Volume (30 Days)
- DAC 89.9K
- NVAX 4.3M
- Earning Date
- DAC 08-04-2025
- NVAX 08-07-2025
- Dividend Yield
- DAC 3.78%
- NVAX N/A
- EPS Growth
- DAC N/A
- NVAX N/A
- EPS
- DAC 24.48
- NVAX 2.97
- Revenue
- DAC $1,013,968,000.00
- NVAX $1,254,962,000.00
- Revenue This Year
- DAC $2.55
- NVAX $55.39
- Revenue Next Year
- DAC N/A
- NVAX N/A
- P/E Ratio
- DAC $3.70
- NVAX $2.36
- Revenue Growth
- DAC 3.10
- NVAX 25.92
- 52 Week Low
- DAC $65.40
- NVAX $5.01
- 52 Week High
- DAC $91.00
- NVAX $17.81
- Technical
- Relative Strength Index (RSI)
- DAC 60.15
- NVAX 54.21
- Support Level
- DAC $87.18
- NVAX $6.84
- Resistance Level
- DAC $90.40
- NVAX $7.06
- Average True Range (ATR)
- DAC 1.89
- NVAX 0.28
- MACD
- DAC 0.12
- NVAX 0.04
- Stochastic Oscillator
- DAC 89.16
- NVAX 79.38
About DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.